RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME
Publication
, Conference
Sanders, D; Juel, V; Harati, Y; Smith, AG; Peltier, A; Marburger, T; Lou, J-S; Pascuzzi, R; Richman, D; Xie, T; Jacobus, L; Ales, K; Jacobus, D
Published in: MUSCLE & NERVE
2015
Duke Scholars
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
2015
Volume
52
Start / End Page
S13 / S13
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanders, D., Juel, V., Harati, Y., Smith, A. G., Peltier, A., Marburger, T., … Jacobus, D. (2015). RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME. In MUSCLE & NERVE (Vol. 52, pp. S13–S13).
Sanders, Donald, Vern Juel, Yadollah Harati, A Gordon Smith, Amanda Peltier, Tessa Marburger, Jau-Shin Lou, et al. “RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME.” In MUSCLE & NERVE, 52:S13–S13, 2015.
Sanders D, Juel V, Harati Y, Smith AG, Peltier A, Marburger T, et al. RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME. In: MUSCLE & NERVE. 2015. p. S13–S13.
Sanders, Donald, et al. “RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME.” MUSCLE & NERVE, vol. 52, 2015, pp. S13–S13.
Sanders D, Juel V, Harati Y, Smith AG, Peltier A, Marburger T, Lou J-S, Pascuzzi R, Richman D, Xie T, Jacobus L, Ales K, Jacobus D. RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERT-EATON MYASTHENIC SYNDROME. MUSCLE & NERVE. 2015. p. S13–S13.
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
2015
Volume
52
Start / End Page
S13 / S13
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences